Ibrutinib Contributes to Atrial Arrhythmia through the Autophagic Degradation of Connexins by Inhibiting the PI3K-AKT-mTOR Signaling Pathway
Background: Ibrutinib could increase the risk of atrial fibrillation (AF) in chronic lymphocytic leukemia (CLL) patients. However, the precise mechanism underlying ibrutinib-induced AF remains incompletely elucidated. Methods: We investigated the proportion of ibrutinib-treated CLL patients with new...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
IMR Press
2024-05-01
|
| Sarja: | Frontiers in Bioscience-Landmark |
| Aiheet: | |
| Linkit: | https://www.imrpress.com/journal/FBL/29/5/10.31083/j.fbl2905201 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|